SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Art Baer who wrote (529)3/24/1997 2:07:00 AM
From: William Presti   of 1172
 
Wow! 8-10 million to promote AWARE? I can't imagine that they are
going to burn their cash reserves on this so...my interpretation is that they expect really decent revenue from their H. Pylori test. I can't help but recall one of the people in their marketing department refering to the H. Pylori test as their "gold star". Hope so. I don't correspond with this person any more since, according to Mr. Covell, only company officers may correspond with the general public about company developments.

Also, when I first saw Cholestrak in the pharmacy at our local food store the stock was limited to only 1 or 2 kits at a time. Then after a few months they bumped it up to 3. Last week they put out 4 of them. Now, these are just drops in the bucket, but what it tells me is that the retailers were extremely conservative when ordering Cholestrak and are adjusting their orders/stock to reflect the slow increase in sales. From what I had been told last year, CMTR believed that the conservative orders resulted from retailers' concern about getting stuck with an oversupply as they did when J&J was pushing the product.

Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext